Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
1652.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
-0.02
vs -0.02
Q4.22
N/A
-0.02
vs -0.02
Q1.23
+318%
0.01
vs -0.01
Q2.23
+317%
0.01
vs -0.01
Q3.23
N/A
-0.04
vs -0.02
Q4.23
N/A
-0.04
vs -0.02
Q1.24
N/A
-0.03
vs 0.01
Q2.24
N/A
-0.03
vs 0.01
Q3.24
N/A
-0.11
vs -0.04
Q4.24
N/A
-0.11
vs -0.04
Sales Growth
YoY
Current
Estimates
Q3.22
+90%
163.1M vs 85.7M
Q4.22
+90%
163.1M vs 85.7M
Q1.23
+103%
168.2M vs 82.8M
Q2.23
+103%
168.2M vs 82.8M
Q3.23
-30%
114.6M vs 163.1M
Q4.23
-30%
114.6M vs 163.1M
Q1.24
-42%
98.2M vs 168.2M
Q2.24
-42%
98.2M vs 168.2M
Q3.24
-43%
64.9M vs 114.6M
Q4.24
-43%
64.9M vs 114.6M
Return on Equity
QoQ
Q1.23
+1%
0.01
vs -0.02
Q2.23
+1%
0.01
vs 0.01
Q3.23
-5%
-0.05
vs 0.01
Q4.23
-5%
-0.05
vs -0.05
Q1.24
-4%
-0.04
vs -0.05
Q2.24
-4%
-0.04
vs -0.04
Q3.24
-21%
-0.21
vs -0.04
Q4.24
-21%
-0.21
vs -0.21
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
1652.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
HKSE
Unprofitable
Unprofitable
-0.01Â ( -2.56%)
Relative Strenght
Volume Buzz
-100%
Earning Acce
No
Dist 52w H.
64%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 1652.HK compares to sector?